Exhibit 32.1
Form 10-KSB
Immunotechnology Corporation
File No. 0-24641

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


      In connection with the annual report of Immunotechnology Corporation (the
"Company") on Form 10-KSB for the period ended June 30, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Mark A.
Scharmann, President, Principal Executive Officer and Principal Financial
Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of
my knowledge:

      (1) the Report fully complies with the requirements of Section 13(a) or
15(d)of the Securities Exchange Act of 1934; and

      (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated:  November 17, 2004



/s/ Mark A. Scharmann
President/Principal Executive Officer
Principal Financial Officer